Steroid Premedication Impact on Efficacy and Cutaneous Toxicity of Enfortumab Vedotin for Advanced Urothelial Carcinoma

NOBUKI FURUBAYASHI; MANABU MOCHIDA; ATSUHIRO KIJIMA; YUSHI FUJIMOTO; MOTONOBU NAKAMURA; TAKAHITO NEGISHI

doi:10.21873/invivo.13961

Article Information

vol. 39 no. 3 1607-1614

DOI

https://doi.org/10.21873/invivo.13961

PMID

40295014

Published By

International Institute of Anticancer Research

Print ISSN

0258-851X

Online ISSN

1791-7549

History

Received January 12, 2025
Revision received February 2, 2025
Accepted February 3, 2025
Published online April 28, 2025.

Copyright © 2025 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

NOBUKI FURUBAYASHI ⇑,
MANABU MOCHIDA,
ATSUHIRO KIJIMA,
YUSHI FUJIMOTO,
MOTONOBU NAKAMURA and
TAKAHITO NEGISHI

Department of Urology, NHO Kyushu Cancer Center, Fukuoka, Japan

Nobuki Furubayashi, MD, Ph.D., Department of Urology, National Hospital Organization Kyushu Cancer Center, Notame 3-1-1, Minami-ku, Fukuoka, 811-1395, Japan. Tel: +81 925413231, Fax: +81 925514585, e-mail: furubayashi.nobuki.yc{at}mail.hosp.go.jp

View Full Text